Medicines

Mujaro, anti-obesity injections, allows you to lose weight for at least three years

The pharmaceutical company Lilly presented the results of Munjaro's clinical trial, the longest to date, for three years, weekly injections…

8 hours ago

Where are the funds to fight diseases that affect one billion poor people? | Planet of the future

More than a billion people worldwide suffer from one of the 21 tropical diseases considered neglected by the World Health…

4 weeks ago

A short walk to the pharmacy will prolong your life | Society

Cardiovascular diseases pose a great threat to human life. WHO estimates that nearly 18 million people die each year worldwide…

1 month ago

“The shortage of Ozempic for the treatment of diabetes will be solved in one to two years” – Princess of Asturias Award

Daniel J. Drucker (Montreal, Canada, 1956) is one of the recipients of the Princess of Asturias Prize for Scientific and…

1 month ago

CNIO proposes new treatment for brain metastases using immunotherapy

Researchers from the National Center for Cancer Research (CNIO) propose a new treatment for brain metastases that do not respond…

1 month ago

A protein that stops an opportunistic pathogen

It has two faces. In healthy people it produces mild infectionsHowever, in patients with weakened immunity, it becomes an opportunistic…

4 months ago

Max Nieuwdorp, endocrinologist: “Chronic exposure of our body and brain to cortisol can cause depression” | Health & Wellbeing

To what extent do hormones control what happens in our bodies and minds? Max Nieuwdorp (Brunssum, Netherlands, 47), internist and…

4 months ago

EMA won’t approve promising Alzheimer’s drug

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has rejected the marketing authorisation for Lekembi…

4 months ago

In the Epicenter of Ozempic | Weekly Country

A white building inspired by the insulin molecule holds the secrets of the latest rock stars of the pharmaceutical industry:…

4 months ago

The EMA does not recommend using Lekembi to slow the symptoms of Alzheimer’s disease.

The European Medicines Agency (EMA) yesterday ruled against the approval in the European Union of the drug Lekambi, designed to…

4 months ago